LifeStance Health Group (NASDAQ:LFST) Raised to “Buy” at The Goldman Sachs Group

The Goldman Sachs Group upgraded shares of LifeStance Health Group (NASDAQ:LFST) from a neutral rating to a buy rating in a report issued on Monday, MarketBeat.com reports. They currently have $10.00 price target on the stock.

Separately, Barclays upped their price target on LifeStance Health Group from $6.00 to $7.00 and gave the company an “underweight” rating in a report on Monday, November 11th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $8.70.

LifeStance Health Group Stock Performance

LFST stock opened at $7.75 on Monday. LifeStance Health Group has a fifty-two week low of $4.64 and a fifty-two week high of $9.20. The company has a market capitalization of $2.97 billion, a P/E ratio of -29.81 and a beta of 1.28. The company has a 50-day simple moving average of $7.19 and a 200 day simple moving average of $6.35. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.19.

LifeStance Health Group (NASDAQ:LFST) last issued its quarterly earnings results on Thursday, November 7th. The company reported ($0.02) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.07) by $0.05. LifeStance Health Group had a negative return on equity of 6.66% and a negative net margin of 7.90%. The firm had revenue of $312.70 million during the quarter, compared to analyst estimates of $302.25 million. During the same period last year, the company posted ($0.17) EPS. The firm’s quarterly revenue was up 18.9% on a year-over-year basis. Sell-side analysts predict that LifeStance Health Group will post -0.2 earnings per share for the current fiscal year.

Insider Buying and Selling

In other LifeStance Health Group news, Director Robert Bessler sold 75,000 shares of the stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $7.54, for a total value of $565,500.00. Following the completion of the sale, the director now owns 1,424,447 shares in the company, valued at $10,740,330.38. This represents a 5.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Company insiders own 6.60% of the company’s stock.

Institutional Trading of LifeStance Health Group

Hedge funds and other institutional investors have recently modified their holdings of the company. TD Asset Management Inc acquired a new position in LifeStance Health Group in the 2nd quarter worth about $623,000. Charles Schwab Investment Management Inc. grew its stake in shares of LifeStance Health Group by 36.9% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,104,453 shares of the company’s stock valued at $7,731,000 after buying an additional 297,723 shares in the last quarter. Point72 Asset Management L.P. increased its holdings in LifeStance Health Group by 24.9% in the third quarter. Point72 Asset Management L.P. now owns 1,100,441 shares of the company’s stock worth $7,703,000 after buying an additional 219,329 shares during the last quarter. Landscape Capital Management L.L.C. raised its position in LifeStance Health Group by 43.7% during the third quarter. Landscape Capital Management L.L.C. now owns 367,935 shares of the company’s stock valued at $2,576,000 after acquiring an additional 111,894 shares in the last quarter. Finally, Principal Financial Group Inc. lifted its stake in LifeStance Health Group by 6.1% in the third quarter. Principal Financial Group Inc. now owns 4,116,766 shares of the company’s stock valued at $28,817,000 after acquiring an additional 235,316 shares during the last quarter. 85.50% of the stock is currently owned by hedge funds and other institutional investors.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.